WaveClear, Inc. announces the closing of a $1,125,000 Series-A round of investment led by Hunniwell Lake Ventures. They will use their funds to further develop the CaviClearTM Endovascular System, a minimally invasive and cost-effective ultrasound generated cavitation device for a broad range of endovascular applications. Read More ⇒


2807, 2020

Is Telehealth a Bubble?

July 28th, 2020|Blogs|

Telehealth companies are seeing an exponential rise in their client base due to COVID-19. However, the rise of Internet-based healthcare comes with its own set of issues and potential concerns.

2507, 2020

The Mechanical Destruction of COVID

July 25th, 2020|COVID, Spotlights|

The newly launched company, Shape Theranostics presents an ideal solution to mass disease prevention. CEO Irving Weinberg discusses the power of his magnetic microdevices for targeted mechanical destruction of coronaviruses and other diseases. 

1707, 2020

Where is Kidney Innovation Heading?

July 17th, 2020|Blogs|

Presidential Executive Order on Advancing American Kidney Health marks an important landmark for kidney care delivery in the United States, as many industry figures are calling this a new era for kidney health. 

Hunniwell Lake Ventures (HLV) is a Palo Alto-based VC firm that invests exclusively in medical devices. Its mission is to make surgery safer, more accessible and less invasive by investing in innovations that help surgeons visualize the operative field better, employ surgical tools using improved and advanced technologies to treat the patient, and ensure their speedy recovery through the best wound closure and tissue healing technologies available.

Hunniwell Lake Ventures

See. Treat. Heal.

Towards Intelligent Surgery.